Evidence map›Paper›PMID 27230666›Full record

ArticleBMC infectious diseases2016

Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries.

Amara E Ezeamama, Chun-La He, Ye Shen, Xiao-Ping Yin, Sue C Binder, Carl H Campbell, Stephen Rathbun, Christopher C Whalen, Eliézer K N'Goran, Jürg Utzinger and 14 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 3 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 3 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Effectiveness of Four Different Interventions Against Schistosoma haematobium in a Seasonal Transmission Setting of Côte d'Ivoire: A Cluster Randomized Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. SCORE Operational Research on Moving toward Interruption of Schistosomiasis Transmission.The American journal of tropical medicine and hygiene · 2020
    Trial
  9. Trial
  10. Trial
  11. Five-Year Impact of Different Multi-Year Mass Drug Administration Strategies on ChildhoodThe American journal of tropical medicine and hygiene · 2019
    Trial
  12. Trial
  13. Comparison of the Impact of Different Mass Drug Administration Strategies on Infection withThe American journal of tropical medicine and hygiene · 2018
    Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 11 institutions in 9 countries.

Amara E EzeamamaDepartment of Epidemiology & Biostatistics, University of Georgia, Athens, GA, USA. aezeamam@uga.edu.
Chun-La HeDepartment of Epidemiology & Biostatistics, University of Georgia, Athens, GA, USA.
Ye ShenDepartment of Epidemiology & Biostatistics, University of Georgia, Athens, GA, USA.
Xiao-Ping YinDepartment of Epidemiology & Biostatistics, University of Georgia, Athens, GA, USA.
Sue C BinderCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, USA.
Carl H CampbellCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, USA.
Stephen RathbunDepartment of Epidemiology & Biostatistics, University of Georgia, Athens, GA, USA.
Christopher C WhalenDepartment of Epidemiology & Biostatistics, University of Georgia, Athens, GA, USA.
Eliézer K N'GoranUnité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, Abidjan, Côte d'Ivoire.
Jürg UtzingerSwiss Tropical and Public Health Institute, Basel, Switzerland.
Annette OlsenUniversity of Copenhagen, Copenhagen, Denmark.
Pascal MagnussenUniversity of Copenhagen, Copenhagen, Denmark.
Safari Kinung'hiNational Institute for Medical Research, Mwanza, Tanzania.
Alan FenwickSchistosomiasis Control Initiative, Imperial College, London, UK.
Anna PhillipsSchistosomiasis Control Initiative, Imperial College, London, UK.
Josefo FerroCatholic University of Mozambique, Beira, Mozambique.
Diana M S KaranjaCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Pauline N M MwinziCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Susan MontgomeryCenters for Disease Control and Prevention, Atlanta, GA, USA.
W Evan SecorCenters for Disease Control and Prevention, Atlanta, GA, USA.
Amina HamidouRéseau International Schistosomoses, Environnement, Aménagement et Lutte (RISEAL-Niger), Niamey, Niger.
Amadou GarbaRéseau International Schistosomoses, Environnement, Aménagement et Lutte (RISEAL-Niger), Niamey, Niger.
Charles H KingCenter for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA.
Daniel G ColleyCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, USA.
University of Georgia · USCenters for Disease Control and Prevention · USCentre de Recherche Médicale et Sanitaire · NEImperial College London · GBKenya Medical Research Institute · KEUniversity of Copenhagen · DKCatholic University of Mozambique · MZCenter for Global Health · USNational Institute for Medical Research · TZSwiss Tropical and Public Health Institute · CHUniversité Félix Houphouët-Boigny · CI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) was established in 2008 to answer strategic questions about schistosomiasis control. For programme managers, a high-priority question is: what are the most cost-effective strategies for delivering preventive chemotherapy (PCT) with praziquantel (PZQ)? This paper describes the process SCORE used to transform this question into a harmonized research protocol, the study design for answering this question, the village eligibility assessments and data resulting from the first year of the study.

methodsBeginning in 2009, SCORE held a series of meetings to specify empirical questions and design studies related to different schedules of PCT for schistosomiasis control in communities with high (gaining control studies) and moderate (sustaining control studies) prevalence of Schistosoma infection among school-aged children. Seven studies are currently being implemented in five African countries. During the first year, villages were screened for eligibility, and data were collected on prevalence and intensity of infection prior to randomisation and the implementation of different schemes of PZQ intervention strategies.

resultsThese studies of different treatment schedules with PZQ will provide the most comprehensive data thus far on the optimal frequency and continuity of PCT for schistosomiasis infection and morbidity control.

conclusionsWe expect that the study outcomes will provide data for decision-making for country programme managers and a rich resource of information to the schistosomiasis research community.

trial registrationThe trials are registered at International Standard Randomised Controlled Trial registry (identifiers: ISRCTN99401114 , ISRCTN14849830 , ISRCTN16755535 , ISRCTN14117624 , ISRCTN95819193 and ISRCTN32045736 ).

Indexed as

Randomized Controlled Trials as TopicResearch DesignAfricaAnimalsAnthelminticsChildChild, PreschoolFemaleHumansMalePraziquantelPrevalencePreventive Health ServicesSchistosoma haematobiumSchistosoma mansoniSchistosomiasisAnthelminticsPraziquantelControlCôte d’IvoireKenyaMozambiqueNigerPraziquantelPreventive chemotherapySchistosoma haematobiumSchistosoma mansoniSchistosomiasisTanzania

Identifiers

PMID27230666
PMCPMC4880878
OpenAlexW2401327237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.